Millennium Management’s SpyGlass Pharma SGP Stock Holding History

Millennium Management’s Portfolio SGP Stock Details SGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.1M	Buy	+468,794	New	+$12.6M	0.01%	1986

Other funds holding SGP

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Millennium Management's SGP Position: Q1 2026 in Review

Millennium Management opened a new position in SpyGlass Pharma (SGP) in Q1 2026: 468,794 shares worth $12.1M. The stake represents 0.01% of the portfolio and ranks #1986 among its holdings.

35 funds tracked by Wall St. Rank hold SGP as of Q1 2026.

Millennium Management held 468,794 shares of SpyGlass Pharma worth $12.1M as of Q1 2026.
SpyGlass Pharma was a new Millennium Management position in Q1 2026.
SpyGlass Pharma made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1986 holding.
35 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.